Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Generic
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| ZTS | Zoetis, Inc. | -3.04% | 194.24 | 1.9% | $428.73m | |
| TEVA | Teva Pharmaceutical Industries Ltd. | -3.23% | 8.24 | 2.0% | $77.15m | |
| RDY | Dr. Reddy's Laboratories Ltd. | -3.30% | 57.73 | 2.0% | $5.35m | |
| TXMD | TherapeuticsMD, Inc. | -4.34% | 0.30 | 14.2% | $2.30m | |
| JAGX | Jaguar Health, Inc. | -5.17% | 0.77 | 2.6% | $1.61m | |
| TARO | Taro Pharmaceutical Industries Ltd. | -2.53% | 45.11 | 6.6% | $0.96m | |
| ABEO | Abeona Therapeutics, Inc. | -4.74% | 0.22 | 2.5% | $0.84m | |
| COCP | Cocrystal Pharma, Inc. | -9.36% | 0.48 | 0.0% | $0.40m | |
| LFVN | LifeVantage Corp. | 1.41% | 6.13 | 3.6% | $0.28m | |
| CPHI | China Pharma Holdings, Inc. | -5.01% | 0.35 | 0.1% | $0.10m |
Company Profile
Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB); ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in New York, NY.